| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 03/25/2009 | EP2037739A2 Benzyl-substituted quinolone m1 receptor positive allosteric modulators |
| 03/25/2009 | EP1610790A4 Anticancer compounds |
| 03/25/2009 | EP1472228B1 Process for the manufacture of hmg-coa reductase inhibitors |
| 03/25/2009 | CN101395137A Substituted 2-amino-4-phenyl-dhydroquinolines, method for the production thereof, use thereof as medicaments, and medicaments containing them |
| 03/25/2009 | CN101395106A Dibenzoanthracene compound and organic light emitting device having the same |
| 03/25/2009 | CN101391980A Method for preparing 6-hydroxyl-3,4dihydro-2(1H)-quinolinone |
| 03/25/2009 | CN100471842C Quinolone derivative or its salt |
| 03/25/2009 | CN100471841C (2-carboxamido) (3-amino) thiophene compounds |
| 03/24/2009 | US7507828 Such as quinoline-8-carboxylic acid [5-(2-mercapto-acetylamino)-pentyl]-amide; increasing sensitivity of cancer cells to radiotherapy cytotoxic effects; neurological diseases |
| 03/24/2009 | US7507823 Water is introduced to a stream of supercritical fluid which is then allowed to mix with a stream including a mixture including aripiprazole and a solvent; mixing results in the substantially simultaneous dispersion and extraction of the aripiprazole from the mixture by the supercritical fluid |
| 03/24/2009 | US7507767 Sulfonamide-containing benzene derivatives which exhibit anti-inflammatory and immunodulatory activity |
| 03/24/2009 | US7507749 Antitumor agents |
| 03/24/2009 | US7507732 6,7-Dihydro-5H-cyclopenta[b]pyridine and 5,6,7,8-tetrahydroquinoline compounds; 5-HT2c receptor agonists; to treat diseases like obesity, depression, atypical depression, anxiety, epilepsy, lower urinary tract dysfunction; less toxic; selectivity |
| 03/24/2009 | CA2431100C Dihydroindole and tetrahydroquinoline derivatives |
| 03/19/2009 | WO2009036161A1 Process and intermediates for preparing integrase inhibitors |
| 03/19/2009 | WO2009035951A2 Soluble epoxide hydrolase inhibitors |
| 03/19/2009 | WO2009035662A1 Deuterated 4 -oxoquinoline derivatives for the treatment of hiv infection |
| 03/19/2009 | WO2008135886A3 Quinoline derivatives for use in the inhibition of the growth of tumour cells |
| 03/19/2009 | WO2008032099A3 Process for the preparation of montelukast, and intermediates therefor |
| 03/19/2009 | WO2005076861A3 Compounds that inhibit hiv particle formation |
| 03/19/2009 | US20090076271 Process for preparing intermediates of HMG-CoA reductase inhibitors |
| 03/19/2009 | US20090076077 Methods and Compositions for Selectin Inhibition |
| 03/19/2009 | US20090076076 Inhibitors of cysteine proteases and methods of use thereof |
| 03/19/2009 | US20090076073 Therapeutic amides |
| 03/19/2009 | US20090076072 Deuterium-enriched tafenoquine |
| 03/19/2009 | US20090075978 Substituted propiolic acid amides and their use for producing drugs |
| 03/19/2009 | US20090075975 Arylsulfonamides and uses related thereto |
| 03/19/2009 | US20090074746 Compounds to treat alzheimer's disease |
| 03/19/2009 | CA2698825A1 Deuterated 4 -oxoquinoline derivatives for the treatment of hiv infection |
| 03/19/2009 | CA2698245A1 Process and intermediates for preparing integrase inhibitors |
| 03/18/2009 | EP2036557A1 Antitumor agent for thyroid cancer |
| 03/18/2009 | EP2035384A2 Process for synthesizing piperazine-piperidine compounds |
| 03/18/2009 | EP2000137A9 Triglyceride-lowering agent and hyperinsulinism-ameliorating agent |
| 03/18/2009 | EP1689380A4 Method for treating adamts-5-associated disease |
| 03/18/2009 | CN101386593A Norfloxacin glutamate hydrate and preparation and use thereof |
| 03/18/2009 | CN101386592A Method for preparing pitavastatin calcium raw material medicine using asymmetric hydrogenation |
| 03/17/2009 | US7504512 BCL-X1 protein inhibitors; anticarcinogenic agents |
| 03/17/2009 | US7504508 PGD2 receptor antagonists for the treatment of inflammatory diseases |
| 03/17/2009 | US7504506 Therapeutic compounds and uses thereof |
| 03/17/2009 | US7504504 Methods of preparing aripiprazole crystalline forms |
| 03/17/2009 | US7504437 Acetylcholinesterase inhibitor; Alzheimer's diseases, Hubtington disease, antidepressants |
| 03/17/2009 | US7504436 Bioisosteres of actinonin |
| 03/17/2009 | US7504416 4-substituted quinolines as antitumor agents |
| 03/17/2009 | US7504415 Therapeutic agent for glomerular disease |
| 03/17/2009 | US7504393 Benzylamine analogues |
| 03/17/2009 | CA2412161C Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 03/17/2009 | CA2316351C Benzopyran and benzothiopyran derivatives having retinoid antagonist-like activity |
| 03/17/2009 | CA2179407C Process for the preparation of leukotriene antagonists |
| 03/12/2009 | WO2009031705A1 PHARMACEUTICAL COMPOSITION FOR INHIBITING ACCUMULATION OF AMYLOID-β PROTEIN |
| 03/12/2009 | WO2009030715A1 Arylsulfonylaminomethylphosphonic acid derivatives, the preparation thereof and the use thereof as pharmaceutical compositions |
| 03/12/2009 | WO2009030469A1 Fungicidal 2-alkylthio-2-quinolinyloxy-acetamide deritvatives |
| 03/12/2009 | WO2009030467A2 Saturated and insaturated bi- or tricyclic aryloxyacetamide derivatives and their use as fungicides |
| 03/12/2009 | US20090069564 Methods and Compositions for Selectin Inhibition |
| 03/12/2009 | US20090069373 Quinoline Acids |
| 03/12/2009 | US20090069338 Method for predicting skin sensitizing activity of compounds |
| 03/12/2009 | US20090069316 Novel quinoline derivatives |
| 03/12/2009 | US20090069282 Alkyne compounds with mch antagonistic activity and medicaments comprising these compounds |
| 03/12/2009 | CA2698665A1 Pharmaceutical composition for inhibiting amyloid-beta protein accumulation |
| 03/12/2009 | CA2698486A1 Arylsulfonylaminomethylphosphonic acid derivatives, the preparation thereof and the use thereof as pharmaceutical compositions |
| 03/12/2009 | CA2696942A1 Fungicidal 2-alkylthio-2-quinolinyloxy-acetamide derivatives |
| 03/12/2009 | CA2696320A1 Novel fungicides |
| 03/11/2009 | EP2034000A2 Electroluminescent iridium compounds having red-orange or red emission and devices made with such compounds |
| 03/11/2009 | EP2033954A1 6-(heterocycle-substituted benzyl)-4-oxoquinoline compound and use of the same as hiv integrase inhibitor |
| 03/11/2009 | EP2033953A1 Vanilloid receptor modulators |
| 03/11/2009 | EP2033952A1 Nitrogen-containing Heteroaryl compounds having HIV Integrase Inhibitory Activity |
| 03/11/2009 | EP2032538A2 Quinoline compounds and methods of use |
| 03/11/2009 | EP1879580B1 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility |
| 03/11/2009 | EP1694689B1 Monocyclopentadienyl complexes |
| 03/11/2009 | EP1631533B1 Novel process for stereoselective reduction of beta-ketoesters |
| 03/11/2009 | EP1566385B1 Phosphorescent compound and electroluminescent element including the same |
| 03/11/2009 | CN101381345A Tetrahydroquinoline derivatives and a process for preparing the same |
| 03/11/2009 | CN101381344A Preparation method of 2-cyclopropyl-4-(4'-fluorophenyl)quinoline-3-methanol |
| 03/11/2009 | CN100467447C Thioamide compound or its salt and cytokine production inhibitor containing the same |
| 03/10/2009 | US7501517 Process for making montelukast and intermediates therefor |
| 03/10/2009 | US7501516 3-Cyanoquinolines 4-substituted by a methylenedioxyphenyl group that is attached by a methylene, oxy, thio, sulfinyl, sulfonyl or amino group; antitumor agents |
| 03/10/2009 | US7501386 Lubricants for automotive and truck crankcase lubricants; as well as transmission lubricants, gear lubricants, hydraulic fluids, compressor oils, diesel and marine lubricants; superior oxidation inhibition; Phenyl-(1,2,3,4-tetrahydro-quinolin-6-yl)-amine, diphenylamine |
| 03/05/2009 | WO2009029617A1 Diarylamine-substituted quinolones useful as inducible nitric oxide synthase inhibitors |
| 03/05/2009 | WO2009027990A1 Salts of montelukast and process therefor |
| 03/05/2009 | WO2009027730A1 Quinolin-4-one and 4-oxodihydrocinnoline derivatives as inhibitors of poly(adp-ribose)polymerase (parp) |
| 03/05/2009 | US20090062530 Substituted arylalkanoic acid derivatives and use thereof |
| 03/05/2009 | US20090062284 Thio-Substituted Biarylmethanesulfinyl Derivatives |
| 03/05/2009 | US20090062280 Ophthalmic Compositions for Treating Ocular Hypertension |
| 03/05/2009 | US20090062279 Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents |
| 03/05/2009 | CA2697971A1 Quinolin-4-one and 4-oxodihydrocinnoline derivatives as inhibitors of poly(adp-ribose)polymerase (parp) |
| 03/05/2009 | CA2695503A1 Tsh receptor antagonizing tetrahydroquinoline compounds |
| 03/04/2009 | EP2029596A2 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzothiazepines, the preparation and use thereof, and compositions containing the same |
| 03/04/2009 | EP2029544A1 Pyrrolidine derivatives useful as bace inhibitors |
| 03/04/2009 | EP2028938A1 3,4-disubstituted coumarin and quinolone compounds |
| 03/04/2009 | EP1776343B1 Quinoline derivatives as neurokinin receptor antagonists |
| 03/04/2009 | CN100465158C An amino-substituted ethylamino beta2- adrenergic receptor agonist |
| 03/03/2009 | US7498442 Quinolinone-carboxamide compounds |
| 03/03/2009 | US7498343 Mycobacterial inhibitors |
| 03/03/2009 | US7498323 Spiro-piperidine compounds and medicinal use thereof |
| 02/26/2009 | WO2009026408A1 Therapeutic quinoline and naphthalene derivatives |
| 02/26/2009 | WO2009025265A1 Piperazine derivative |
| 02/26/2009 | WO2009025160A1 Transition metal complex and process for producing conjugated aromatic compound with the transition metal complex |
| 02/26/2009 | WO2009024611A2 4-benzylaminoquinolines, pharmaceutical compositions containing them and their use |
| 02/26/2009 | WO2009024095A1 Method of making and administering quinoline derivatives as anti-cancer agents |
| 02/26/2009 | WO2008154402A3 Hdac inhibitors and hormone targeted drugs for the treatment of cancer |
| 02/26/2009 | US20090054653 Enantioselektive preparation of quinoline derivative |